SUPN Supernus Pharmaceuticals, Inc.
$41.64▼ -0.12%
Healthcare
Other
After hours
$41.64▲ +0.00%
Sep 11, 7:30 PM ET
Volume 707.2K
Avg Volume (10D) 526.2K
Key Metrics & Fundamentals
Market Cap
$2.42B
P/E Ratio
–
Div Yield
–%
52W Range
41.11 - 59.68
% vs 50 MA
-10.01%
% vs 200 MA
-14.03%
RSI-14
30.8
MACD Histogram
-0.3400
Beta (1Y vs SPY)
0.44
Free Cash Flow
-$5.38M
Gross Rev
$219.06M
Gross Profit
$185.39M
EBITDA
$25.33M
COGS
$33.67M
Operating Exp
$188.43M
Operating Income
-$3.04M
EBIT
-$3.04M
Pretax Income
-$57.65M
Net Income
-$58.37M
EPS (Diluted)
-1.01
Price & Volume History
Loading chart…
Recent News
1 of Wall Street’s Favorite Stocks with Promising Prospects and 2 Facing Headwinds
StockStory · Sep 8, 2026 8:31 PM
Supernus Pharmaceuticals to Participate in September Investor Conferences
GlobeNewswire · Sep 2, 2026 8:30 PM
3 Out-of-Favor Stocks We’re Skeptical Of
StockStory · Sep 2, 2026 8:36 AM
Chloe Kim Teams Up with Qelbree®, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help Empower People Navigating ADHD
GlobeNewswire · Aug 31, 2026 12:30 PM
3 Small-Cap Stocks with Open Questions
StockStory · Aug 25, 2026 10:54 AM
Is the Options Market Predicting a Spike in Supernus Pharmaceuticals Stock?
Zacks · Aug 24, 2026 9:45 PM
Indivior's Supernus Merger Could Broaden Its Growth Engine in 2026
Zacks · Aug 21, 2026 4:40 PM
Should Investors Buy INDV as Sublocade Growth Meets Rising Risks?
Zacks · Aug 21, 2026 2:48 PM
Should You Buy, Sell or Hold Biogen Stock After a 9% Rise in a Month?
Zacks · Aug 20, 2026 2:12 PM
1 Healthcare Stock with Exciting Potential and 2 We Ignore
StockStory · Aug 18, 2026 10:05 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See SUPN's money flow as a full page
Social Sentiment
No Reddit posts found for SUPN.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.